Skip to main content

Soft Tissue Lesions

  • Chapter
  • First Online:
Pathology of the Head and Neck

Abstract

This chapter covers the broad spectrum of soft tissue lesions occurring in the head and neck, based on the current WHO classification. Most of these lesions are very rare, and there are a lot of overlapping features that hamper appropriate classification. Hence, not only morphological but also immunohistochemical and molecular genetic criteria helpful in making the diagnosis and comprehensive differential diagnoses are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Golledge J, Fisher C. Head and neck liposarcoma. Cancer. 1995;76(6):1051–8.

    Article  CAS  PubMed  Google Scholar 

  2. Furlong MA, Fanburg-Smith JC, Childers EL. Lipoma of the oral and maxillofacial region: site and subclassification of 125 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(4):441–50.

    Article  PubMed  Google Scholar 

  3. Allon I, Aballo S, Dayan D, Vered M. Lipomatous tumors of the oral mucosa: histomorphological, histochemical and immunohistochemical features. Acta Histochem. 2011;113(8):803–9.

    Article  CAS  PubMed  Google Scholar 

  4. Manor E, Sion-Vardy N, Joshua BZ, Bodner L. Oral lipoma: analysis of 58 new cases and review of the literature. Ann Diagn Pathol. 2011;15(4):257–61.

    Article  PubMed  Google Scholar 

  5. Nishio J. Contribution of cytogenetics and molecular cytogenetics to the diagnosis of adipocytic tumors. J Biomed Biotechnol. 2011;2011:5240–67.

    Article  Google Scholar 

  6. Nielsen GP, Mandahl N. Lipoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 20–1.

    Google Scholar 

  7. Coffin CM, Alaggio R. Adipose and myxoid tumors of childhood and adolescence. Pediatr Dev Pathol. 2012;15(1 Suppl):239–54.

    Article  PubMed  Google Scholar 

  8. Miettinen MM, Mandahl N. Spindle cell/pleomorphic lipoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 29–30.

    Google Scholar 

  9. Chen B, Mariño-Enriquez A, Fletcher CD, Hornick JL. Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications. Am J Surg Pathol. 2012;36(8):1119–28.

    Article  PubMed  Google Scholar 

  10. Weiss SW. Lipomatous tumors. Monogr Pathol. 1996;38:207–39.

    CAS  PubMed  Google Scholar 

  11. Maggiani F, Debiec-Rychter M, Verbeek G, Sciot R. Extramammary myofibroblastoma is genetically related to spindle cell lipoma. Virchows Arch. 2006;449(2):244–7.

    Article  PubMed  Google Scholar 

  12. Brimo MB, Dion D, Huwait H, Turcotte R, Nahal A. The utility of MDM2 und CDK4 immunohistochemistry in needle biopsy interpretation of lipomatous tumors: a study of 21 Tru-Cut biopsy cases. Histopathology. 2008;52(7):892–5.

    Google Scholar 

  13. Thway K, Flora R, Shah C, Olmos D, Fisher C. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am J Surg Pathol. 2012;36(3):462–9.

    Article  PubMed  Google Scholar 

  14. Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma. A clinicopathologic study of 170 cases. Am J Surg Pathol. 2001;25(6):809–14.

    Article  CAS  PubMed  Google Scholar 

  15. Maire G, Forus A, Foa C, Bjerkehagen B, Mainguené C, Kresse SH, et al. 11q13 alterations in two cases of hibernoma: large heterogenous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes Chromosomes Cancer. 2003;37(4):389–95.

    Article  CAS  PubMed  Google Scholar 

  16. de Saint Aubain Somerhausen N, Coindre JM, Debiec-Rychter M, Delplace J, Sciot R. Lipoblastoma in adolescents and young adults: report of six cases with FISH analysis. Histopathology. 2008;52(3):294–8.

    Article  PubMed  Google Scholar 

  17. Chung EB, Enzinger FM. Benign lipoblastomatosis. An analysis of 35 cases. Cancer. 1973;32(2):482–92.

    Article  CAS  PubMed  Google Scholar 

  18. Michal M, Fetsch JF, Hes O, Miettinen M. Nuchal-type fibroma: a clinicopathologic study of 52 cases. Cancer. 1999;85(1):156–63.

    Article  CAS  PubMed  Google Scholar 

  19. Coffin CM, Hornick JL, Zhou H, Fletcher CD. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas. Am J Surg Pathol. 2007;31(3):410–6.

    Article  PubMed  Google Scholar 

  20. Wehrli BM, Weiss SW, Yandow S, Coffin CM. Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis. Am J Surg Pathol. 2001;25(5):645–51.

    Article  CAS  PubMed  Google Scholar 

  21. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, et al. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011;91(10):1427–33.

    Article  CAS  PubMed  Google Scholar 

  22. Lauer DH, Enzinger FM. Cranial fasciitis of childhood. Cancer. 1980;45(2):401–6.

    Article  CAS  PubMed  Google Scholar 

  23. Rosenberg AE. Pseudosarcomas of soft tissue. Arch Pathol Lab Med. 2008;132(4):579–86.

    PubMed  Google Scholar 

  24. Dayan D, Nasrallah V, Vered M. Clinico-pathologic correlation of myofibroblastic tumors of the oral cavity: 1. Nodular fasciitis. J Oral Pathol Med. 2005;34(7):426–35.

    Article  PubMed  Google Scholar 

  25. Weinreb I, Shaw AJ, Perez-Ordoñez B, Goldblum JR, Rubin BP. Nodular fasciitis of the head and neck region: a clinicopathologic description in a series of 30 cases. J Cutan Pathol. 2009;36(11):1168–73.

    Article  PubMed  Google Scholar 

  26. Montgomery EA, Meis JM. Nodular fasciitis. Its morphologic spectrum and immunohistochemical profile. Am J Surg Pathol. 1991;15(10):942–8.

    Article  CAS  PubMed  Google Scholar 

  27. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013;463(1):97–8.

    Article  PubMed  Google Scholar 

  28. Granter SR, Badizadegan K, Fletcher CD. Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol. 1998;22(5):513–25.

    Article  CAS  PubMed  Google Scholar 

  29. Mentzel T, Dei Tos AP, Sapi Z, Kutzner H. Myopericytoma of skin and soft tissues. Clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2006;30(1):104–13.

    Article  PubMed  Google Scholar 

  30. Coffin CM, Alaggio R. Fibroblastic and myofibroblastic tumors in children and adolescents. Pediatr Dev Pathol. 2012;15(1 Suppl):127–80.

    Article  PubMed  Google Scholar 

  31. Fletcher CD. Distinctive soft tissue tumors of the head and neck. Mod Pathol. 2002;15(3):324–30.

    Article  PubMed  Google Scholar 

  32. Miettinen M. Benign fibroblastic and myofibroblastic proliferations in children. In: Miettinen M, editor. Modern soft tissue pathology. Tumors and non-neoplastic conditions. New York: Cambridge University Press; 2010. p. 273–9.

    Chapter  Google Scholar 

  33. Miettinen M. Smooth muscle tumors of soft tissue and non-uterine viscera: biology and prognosis. Mod Pathol. 2014;27(Suppl1):S17–29.

    Article  PubMed  Google Scholar 

  34. Mosquera JM, Sboner A, Zhang L, Chen CL, Sung YS, Chen HW, et al. Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes Chromosomes Cancer. 2013;52(11):1075–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gleason BC, Fletcher CD. Deep “benign” fibrous histiocytoma: clinicopathologic analysis of 69 cases of a rare tumor indicating occasional metastatic potential. Am J Surg Pathol. 2008;32(3):354–62.

    Article  PubMed  Google Scholar 

  36. Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS, et al. Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing. Nat Genet. 2013;45(2):180–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Chmielecki J, Crago AM, Rosenberg M, O’Connor R, Walker SR, Ambrogio L, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet. 2013;45(2):131–2.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Mohajeri A, Tayebwa J, Collin A, Nilsson J, Magnusson L, von Steyern FV, et al. Comprehensive genetic analysis identifies a pathognomic NAB2/STAT6 fusion gene, nonrandom secondary genomic imbalances and a characteristic gene expression profile in solitary fibrous tumor. Genes Chromosomes Cancer. 2013;52(10):873–86.

    Article  CAS  PubMed  Google Scholar 

  39. Doyle LA, Vivero M, Fletcher CD, Mertens F, Hornick JL. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014;27(3):390–5.

    CAS  PubMed  Google Scholar 

  40. Vogels RJ, Vlenterie M, Versleijen-Jonkers YM, Ruijter E, Bekers EM, Verdijk MA, et al. Solitary fibrous tumor – clinicopathologic, immunohistochemical and molecular analysis of 28 cases. Diagn Pathol. 2014;9(1):224.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Mentzel T, Wiesner T, Cerroni L, Hantschke M, Kutzner H, Rütten A, et al. Malignant dermatofibroma: clinicopathological, immunohistochemical, and molecular analysis of seven cases. Mod Pathol. 2013;26(2):256–67.

    Article  PubMed  Google Scholar 

  42. Doyle LA, Fletcher CD. Metastasizing “benign” cutaneous fibrous histiocytoma: a clinicopathologic analysis of 16 cases. Am J Surg Pathol. 2013;37(4):484–95.

    Article  PubMed  Google Scholar 

  43. Smith BC, Ellis GL, Meis-Kindblom JM, Williams SB. Ectomesenchymal chondromyxoid tumor of the anterior tongue. Nineteen cases of a new clinicopathologic entity. Am J Surg Pathol. 1995;19(5):519–30.

    Article  CAS  PubMed  Google Scholar 

  44. Nikitakis NG, Argyris P, Sklavounou A, Papadimitrou JC. Oral myoepithelioma of soft tissue origin: report of a new case and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;110(5):e48–51.

    Article  PubMed  Google Scholar 

  45. Cardin MJ, Fiset PO, Zeitouni AG, Caglar D. Ectomesenchymal chondromyxoid tumor of the posterior tongue. Head Neck Pathol. 2014;8(3):329–33.

    Google Scholar 

  46. Gleason BC, Fletcher CD. Myoepithelial carcinoma of soft tissue in children: an aggressive neoplasm analyzed in a series of 29 cases. Am J Surg Pathol. 2007;31(12):1813–24.

    Article  PubMed  Google Scholar 

  47. Woo VL, Angiero F, Fantasia JE. Myoepithelioma of the tongue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(5):581–9.

    Article  PubMed  Google Scholar 

  48. Fletcher CD, Antonescu CR, Heim S, Hornick JL. Myoepithelioma/myoepithelial carcinoma/mixed tumor. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 208–9.

    Google Scholar 

  49. Hasegawa SL, Mentzel T, Fletcher CD. Schwannomas of the sinonasal tract and nasopharynx. Mod Pathol. 1997;10(8):777–84.

    CAS  PubMed  Google Scholar 

  50. Hornick JL, Fletcher CD. Soft tissue perineurioma: clinicopathologic analysis of 81 cases including those with atypical histologic features. Am J Surg Pathol. 2005;29(7):845–58.

    Article  PubMed  Google Scholar 

  51. Cates JM, Coffin CM. Neurogenic tumors of soft tissue. Pediatr Dev Pathol. 2012;15(1 Suppl):62–107.

    Article  PubMed  Google Scholar 

  52. Rodriguez FJ, Folpe AL, Giannini C, Perry A. Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problems. Acta Neuropathol. 2012;123(3):295–319.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Laskin WB, Fetsch JF, Lasota J, Miettinen M. Benign epithelioid peripheral nerve sheath tumors of the soft tissues: clinicopathologic spectrum of 33 cases. Am J Surg Pathol. 2005;29(1):39–51.

    Article  PubMed  Google Scholar 

  54. Billings SD, Giblen G, Fanburg-Smith JC. Superficial low-grade fibromyxoid sarcoma (Evans tumor): a clinicopathologic analysis of 19 cases with a unique observation in the pediatric population. Am J Surg Pathol. 2005;29(2):204–10.

    Article  PubMed  Google Scholar 

  55. Karamchandani JR, Nielsen TO, van de Rijn M, West RB. Sox10 and S100 in the diagnosis of soft-tissue neoplasms. Appl Immunohistochem Mol Morphol. 2012;20(5):445–50.

    Article  CAS  PubMed  Google Scholar 

  56. Antonescu CR, Perry A, Woodruff. Schwannoma (including variants). In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 170–2.

    Google Scholar 

  57. Thway K, Fisher C. Malignant peripheral nerve sheath tumor: pathology and genetics. Ann Diagn Pathol. 2014;18(2):109–16.

    Article  PubMed  Google Scholar 

  58. Hornick JL, Bundock EA, Fletcher CD. Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors. Am J Surg Pathol. 2009;33(10):1554–61.

    Article  PubMed  Google Scholar 

  59. Erlandson RA. The enigmatic perineurial cell and its participation in tumors and tumorlike entities. Ultrastruct Pathol. 1991;15(4–5):335–51.

    Article  CAS  PubMed  Google Scholar 

  60. Folpe AL, Billings SD, McKenney JK, Walsh SV, Nusrat A, Weiss SW. Expression of claudin-1, a recently described tight junction-associated protein, distinguishes soft tissue perineurioma from potential mimics. Am J Surg Pathol. 2002;26(12):1620–6.

    Article  PubMed  Google Scholar 

  61. Agaimy A, Buslei R, Coras R, Rubin BP, Mentzel T. Comparative study of soft tissue perineurioma and meningioma using a five-marker immunohistochemical panel. Histopathology. 2014;65(1):60–70.

    Article  PubMed  Google Scholar 

  62. Lasota J, Fetsch JF, Wozniak A, Wasag B, Sciot R, Miettinen M. The neurofibromatosis type 2 gene is mutated in perineurial cell tumors: a molecular genetic study of eight cases. Am J Pathol. 2001;158(4):1223–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Thway K, Fisher C, Debiec-Rychter M, Calonje E. Claudin-1 is expressed in perineurioma-like low-grade fibromyxoid sarcoma. Hum Pathol. 2009;40(11):1586–90.

    Article  CAS  PubMed  Google Scholar 

  64. Macarenco RS, Ellinger F, Oliveira AM. Perineurioma: a distinctive and underrecognized peripheral nerve sheath neoplasm. Arch Pathol Lab Med. 2007;131(4):625–36.

    PubMed  Google Scholar 

  65. Veeresh M, Sudhakara M, Girish G, Naik C. Leiomyoma: a rare tumor in the head and neck and oral cavity: report of 3 cases with review. J Oral Maxillofac Pathol. 2013;17(2):281–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Miettinen MM, Quade B. Leiomyoma of deep soft tissue. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 110–1.

    Google Scholar 

  67. Dry SM, Jorgensen JL, Fletcher CD. Leiomyosarcomas of the oral cavity: an unusual topographic subset easily mistaken for nonmesenchymal tumors. Histopathology. 2000;36(3):210–20.

    Google Scholar 

  68. Hisaoka M, Quade B. Angioleiomyoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 120–1.

    Google Scholar 

  69. Kapadia SB, Meis JM, Frisman DM, Ellis GL, Heffner DK, Hyams VJ. Adult rhabdomyoma of the head and neck: a clinicopathologic and immunophenotypic study. Hum Pathol. 1993;24(6):608–17.

    Article  CAS  PubMed  Google Scholar 

  70. Jo VY, Reith JD, Coindre JM, Fletcher CD. Paratesticular rhabdomyoma: a morphologically distinct sclerosing variant. Am J Surg Pathol. 2013;37(11):1737–42.

    Article  PubMed  Google Scholar 

  71. Parham DM, Alaggio R, Coffin CM. Myogenic tumors in children and adolescents. Pediatr Dev Pathol. 2012;15(1 Suppl):211–38.

    Article  PubMed  Google Scholar 

  72. Parham DM, Barr FG. Rhabdomyoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 124–6.

    Google Scholar 

  73. Fetsch JF, Laskin WB, Michal M, Remotti F, Heffner D, Ellis G, et al. Ectopic hamartomatous thymoma: a clinicopathologic and immunohistochemical analysis of 21 cases with data supporting reclassification as a branchial anlage mixed tumor. Am J Surg Pathol. 2004;28(10):1360–70.

    Article  PubMed  Google Scholar 

  74. Thway K. Angiomatoid fibrous histiocytoma: a review with recent genetic findings. Arch Pathol Lab Med. 2008;132(2):273–7.

    PubMed  Google Scholar 

  75. Antonescu CR, Dal Cin P, Nafa K, Teot LA, Surti U, Fletcher CD, et al. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma. Genes Chromosomes Cancer. 2007;46(12):1051–60.

    Article  CAS  PubMed  Google Scholar 

  76. Antonescu CR, Rossi S. Angiomatoid fibrous histiocytoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 204–5.

    Google Scholar 

  77. Enzinger FM, Weiss SW, Liang CY. Ossifying fibromyxoid tumor of soft parts. A clinicopathological analysis of 59 cases. Am J Surg Pathol. 1989;13(10):817–27.

    Article  CAS  PubMed  Google Scholar 

  78. Folpe AL, Weiss SW. Ossifying fibromyxoid tumor of soft parts: a clinicopathologic study of 70 cases with emphasis on atypical and malignant variants. Am J Surg Pathol. 2003;27(4):421–31.

    Article  PubMed  Google Scholar 

  79. Miettinen M, Finnell V, Fetsch JF. Ossifying fibromyxoid tumor of soft parts – a clinicopathologic and immunohistochemical study of 104 cases with long-term follow-up and a critical review of the literature. Am J Surg Pathol. 2008;32(7):996–1005.

    Article  PubMed  Google Scholar 

  80. Graham RP, Weiss SW, Sukov WR, Goldblum JR, Billings SD, Dotlic S, et al. PHF1 rearrangements in ossifying fibromyxoid tumors of soft parts. A fluorescence in situ hybridization study of 41 cases with emphasis on the malignant variant. Am J Surg Pathol. 2013;37(11):1751–5.

    Article  PubMed  Google Scholar 

  81. Kilpatrick SE, Ward WG, Mozes M, Miettinen M, Fukanaga M, Fletcher CD. Atypical and malignant variants of ossifying fibromyxoid tumor. Clinicopathologic analysis of six cases. Am J Surg Pathol. 1995;19(9):1039–46.

    Article  CAS  PubMed  Google Scholar 

  82. Antonescu CR, Sung YS, Chen CL, Zhang L, Chen HW, Singer S, et al. Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors – molecular characterization shows genetic overlap with endometrial stromal sarcoma. Genes Chromosomes Cancer. 2014;53(2):183–93.

    Article  CAS  PubMed  Google Scholar 

  83. Gebre-Medhin S, Nord KH, Möller E, Mandahl N, Magnusson J, Nilsson J, et al. Recurrent rearrangement of the PHF1 gene in ossifying fibromyxoid tumors. Am J Pathol. 2012;181(3):1069–77.

    Article  CAS  PubMed  Google Scholar 

  84. Goldblum JR, Fletcher JA. Desmoid-type fibromatosis. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 72–3.

    Google Scholar 

  85. Flucke U, Tops BB, van Diest PJ, Slootweg PJ. Desmoid-type fibromatosis of the head and neck region in the pediatric population: a clinicopathological and genetic study of seven cases. Histopathology. 2014;64(6):769–76.

    Article  PubMed  Google Scholar 

  86. Amary MF, Pauwels P, Meulemans E, Roemen GM, Islam L, Idowu B, et al. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Am J Surg Pathol. 2007;31(9):1299–309.

    Article  PubMed  Google Scholar 

  87. Lazar AJ, Tuvin D, Hajibashi S, Habeeb S, Bolshakov S, Mayordomo-Aranda E, et al. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors. Am J Pathol. 2008;173(5):1518–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Salas S, Chibon F, Noguchi T, Terrier P, Ranchere-Vince D, Lagarde P, et al. Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors. Genes Chromosomes Cancer. 2010;49(6):560–8.

    CAS  PubMed  Google Scholar 

  89. Wang WL, Nero C, Pappo A, Lev D, Lazar AJ, Lópes-Terrada D. CTNNB1 genotyping and APC screening in pediatric desmoids tumors: a proposed algorithm. Pediatr Dev Pathol. 2012;15(5):361–7.

    Article  CAS  PubMed  Google Scholar 

  90. Le Guellec S, Soubeyran I, Rochaix P, Filleron T, Neuville A, Hostein I, et al. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics. Mod Pathol. 2012;25(12):1551–8.

    Article  PubMed  CAS  Google Scholar 

  91. Ganly I, Patel SG, Stambuk HE, Coleman M, Ghossein R, Carlson D, et al. Solitary fibrous tumors of the head and neck. Arch Otolaryngol Head Neck Surg. 2006;132(5):517–25.

    Article  PubMed  Google Scholar 

  92. Fletcher CD, Bridge JA, Lee JC. Extrapleural solitary fibrous tumor. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 80–2.

    Google Scholar 

  93. Alawi F, Stratton D, Freedman PD. Solitary fibrous tumor of the oral soft tissues: a clinicopathologic and immunohistochemical study of 16 cases. Am J Surg Pathol. 2001;25(7):900–10.

    Article  CAS  PubMed  Google Scholar 

  94. Zafar H, Takimoto CH, Weiss G. Doege-Potter syndrome: hypoglycemia associated with malignant solitary fibrous tumor. Med Oncol. 2003;20(4):403–8.

    Article  PubMed  Google Scholar 

  95. Gengler C, Guillou L. Solitary fibrous tumor and haemangiopericytoma: evolution of a concept. Histopathology. 2006;48(1):63–74.

    Article  CAS  PubMed  Google Scholar 

  96. Dei Tos AP, Seregard S, Calonje E, Chan JK, Fletcher CD. Giant cell angiofibroma. A distinctive orbital tumor in adults. Am J Surg Pathol. 1995;19(11):1286–93.

    Article  CAS  PubMed  Google Scholar 

  97. Vivero M, Doyle LA, Fletcher CD, Mertens F, Hornick JL. GRIA2 is a novel diagnostic marker for solitary fibrous tumor identified through gene expression profiling. Histopathology. 2014;65(1):71–80.

    Google Scholar 

  98. Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509–20.

    Article  PubMed  Google Scholar 

  99. Mariño-Enrìquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, et al. Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK. Am J Surg Pathol. 2011;35(1):135–44.

    Article  PubMed  Google Scholar 

  100. Mentzel T, Calonje E, Fletcher CD. Leiomyosarcoma with prominent osteoclast-like giant cells. Analysis of eight cases closely mimicking the so-called giant cell variant of malignant fibrous histiocytoma. Am J Surg Pathol. 1994;18(3):258–65.

    Article  CAS  PubMed  Google Scholar 

  101. de Saint Aubain Somerhausen N, Fletcher CD. Leiomyosarcoma of soft tissue in children. Am J Surg Pathol. 1999;23(7):755–63.

    Article  PubMed  Google Scholar 

  102. Yan B, Li Y, Xia H, Li LJ. Primary oral leiomyosarcoma: a retrospective clinical analysis of 20 cases. Oral Dis. 2010;16(2):198–203.

    Article  CAS  PubMed  Google Scholar 

  103. Schütz A, Smeets R, Driemel O, Hakim SG, Kosmehl H, Hanken H, et al. Primary and secondary leiomyosarcoma of the oral and perioral region – clinicopathological and immunohistochemical analysis of a rare entity with a review of the literature. J Oral Maxillofac Surg. 2013;71(6):1132–42.

    Article  PubMed  Google Scholar 

  104. Coindre JM. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med. 2006;130(10):1448–53.

    PubMed  Google Scholar 

  105. Lazar A, Evans HL, Shipley J. Leiomyosarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 111–3.

    Google Scholar 

  106. Ravegnini G, Mariño-Enriquez A, Slater J, Eilers G, Wang Y, Zhu M, et al. MED12 mutations in leiomyosarcoma and extrauterine leiomyoma. Mod Pathol. 2013;26(5):743–9.

    Article  CAS  PubMed  Google Scholar 

  107. Bekers EM, van Engen-van Grunsven AC, Groenen PJ, Westdorp H, Koornstra RH, Bonenkamp JJ, et al. Metastatic melanoma mimicking solitary fibrous tumor: report of two cases. Virchows Arch. 2014;464(2):247–51.

    Article  PubMed  Google Scholar 

  108. Parham DM, Ellison DA. Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med. 2006;130(10):1454–65.

    PubMed  Google Scholar 

  109. Nascimento AF, Fletcher CD. Spindle cell rhabdomyosarcoma in adults. Am J Surg Pathol. 2005;29(8):1106–13.

    PubMed  Google Scholar 

  110. Hawkins DS, Gupta AA, Rudzinski ER. What is new in the biology and treatment of pediatric rhabdomyosarcoma? Curr Opin Pediatr. 2014;26(1):50–6.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Raney RB, Meza J, Anderson JR, Fryer CJ, Donaldson SS, Breneman JC, et al. Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through –IV, 1978–1997. Med Pediatr Oncol. 2002;38(1):22–32.

    Article  PubMed  Google Scholar 

  112. Hawkins WG, Hoos A, Antonescu CR, Urist MJ, Leung DH, Gold JS, et al. Clinicopathologic analysis of patients with adult rhabdomyosarcoma. Cancer. 2001;91(4):794–803.

    Article  CAS  PubMed  Google Scholar 

  113. Cavazzana AO, Schmidt D, Ninfo V, Harms D, Tollot M, Carli M, et al. Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. Am J Surg Pathol. 1992;16(3):229–35.

    Article  CAS  PubMed  Google Scholar 

  114. Nascimento AF, Barr FG. Spindle cell/sclerosing rhabdomyosarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 134–5.

    Google Scholar 

  115. Folpe AL, McKenney JK, Bridge JA, Weiss SW. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma. Am J Surg Pathol. 2002;26(9):1175–83.

    Article  PubMed  Google Scholar 

  116. Mosquera JM, Sboner A, Zhang L, Kitabayashi N, Chen CL, Sung YS, et al. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes Chromosomes Cancer. 2013;52(6):538–50.

    Article  CAS  PubMed  Google Scholar 

  117. Mentzel T, Katenkamp D. Sclerosing, pseudovascular rhabdomyosarcoma in adults. Clinicopathological and immunohistochemical analysis of three cases. Virchows Arch. 2000;436(4):305–11.

    Article  CAS  PubMed  Google Scholar 

  118. Mentzel T, Kuhnen C. Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases. Virchows Arch. 2006;449(5):554–60.

    Article  PubMed  Google Scholar 

  119. Carroll SJ, Nodit L. Spindle cell rhabdomyosarcoma. A brief diagnostic review and differential diagnosis. Arch Pathol Lab Med. 2013;137(8):1155–8.

    Article  PubMed  Google Scholar 

  120. Stock N, Chibon F, Binh MB, Terrier P, Michels JJ, Valo I, et al. Adult-type rhabdomyosarcoma: analysis of 57 cases with clinicopathologic description, identification of 3 morphologic patterns and prognosis. Am J Surg Pathol. 2009;33(12):1850–9.

    Article  PubMed  Google Scholar 

  121. Jo VY, Mariño-Enríquez A, Fletcher CD. Epithelioid rhabdomyosarcoma: clinicopathologic analysis of 16 cases of a morphologically distinct variant of rhabdomyosarcoma. Am J Surg Pathol. 2011;35(10):1523–30.

    Article  PubMed  Google Scholar 

  122. Zin A, Bertorelle R, Dall’Igna P, Manzitti C, Gambini C, Bisogno G, et al. Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study. Am J Surg Pathol. 2014;38(2):273–8.

    Article  PubMed  Google Scholar 

  123. Fisher C. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas. Ultrastruct Pathol. 2004;28(5–6):291–305.

    Article  PubMed  Google Scholar 

  124. Mentzel T. Low-grade myofibroblastic sarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 85–6.

    Google Scholar 

  125. Cai C, Dehner LP, El-Mofty SK. In myofibroblastic sarcomas of the head and neck, mitotic activity and necrosis define grade: a case study and literature review. Virchows Arch. 2013;463(6):827–36.

    Article  PubMed  Google Scholar 

  126. Carlson JW, Fletcher CDM. Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature. Histopathology. 2007;51(4):509–14.

    Article  CAS  PubMed  Google Scholar 

  127. Weiss SW, Enzinger FM. Epithelioid hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982;50(5):970–81.

    Article  CAS  PubMed  Google Scholar 

  128. Mentzel T, Beham A, Calonje E, Katenkamp D, Fletcher CD. Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol. 1997;21(4):363–74.

    Article  CAS  PubMed  Google Scholar 

  129. Deyrup AT, Tighiouart M, Montag AG, Weiss SW. Epithelioid hemangioendothelioma of soft tissue: a proposal for risk stratification based on 49 cases. Am J Surg Pathol. 2008;32(6):924–7.

    Article  PubMed  Google Scholar 

  130. Bruder E, Alaggio R, Kozakewich HP, Jundt G, Dehner LP, Coffin CM. Vascular and perivascular lesions of skin and soft tissues in children and adolescents. Pediatr Dev Pathol. 2012;15(1 Suppl):26–61.

    Article  PubMed  Google Scholar 

  131. Flucke U, Vogels RJ, de Saint Aubain Somerhausen N, Creytens DH, Riedl RG, van Gorp JM, et al. Epithelioid hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases. Diagn Pathol. 2014;9:131.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Errani C, Zhang L, Sung YS, Hajdu M, Singer S, Maki R, et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer. 2011;50(8):644–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Antonescu CR, Le Loarer F, Mosquera JM, Sboner A, Zhang L, Chen CL, et al. Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma. Genes Chromosomes Cancer. 2013;52(8):775–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Evans HL. Low-grade fibromyxoid sarcoma: a clinicopathologic study of 33 cases with long-term follow-up. Am J Surg Pathol. 2011;35(10):1450–62.

    Article  PubMed  Google Scholar 

  135. Evans HL. Low-grade fibromyxoid sarcoma. A report of 12 cases. Am J Surg Pathol. 1993;17(6):595–600.

    Article  CAS  PubMed  Google Scholar 

  136. Lane KL, Shannon RJ, Weiss SW. Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma. Am J Surg Pathol. 1997;21(12):1481–8.

    Article  CAS  PubMed  Google Scholar 

  137. Guillou L, Benhattar J, Gengler C, Gallaher G, Ranchère-Vince D, Collin F, et al. Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma. Am J Surg Pathol. 2007;31(9):1387–402.

    Article  PubMed  Google Scholar 

  138. Arbajian E, Puls F, Magnusson L, Thway K, Fisher C, Sumathi VP, et al. Recurrent EWSR1-CREB3L1 gene fusions in sclerosing epithelioid fibrosarcoma. Am J Surg Pathol. 2014;38(6):801–8.

    Article  PubMed  Google Scholar 

  139. Doyle LA, Möller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2011;35(5):733–41.

    Article  PubMed  Google Scholar 

  140. Mertens F, Fletcher CD, Antonescu CR, Coindre JM, Colecchia M, Domanski HA, et al. Clinicopathologic and molecular genetic characterization of low-grade fibromyxoid sarcoma, and cloning of a novel FUS/CREB3L1 fusion gene. Lab Invest. 2005;85(3):408–15.

    Article  CAS  PubMed  Google Scholar 

  141. Lau PP, Lui PC, Lau GT, Yau DT, Cheung ET, Chan JK. EWSR1-CREB3L1 gene fusion. A novel alternative molecular aberration of low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2013;37(5):734–8.

    Article  PubMed  Google Scholar 

  142. Meis-Kindblom JM, Kindblom LG, Enzinger FM. Sclerosing epithelioid fibrosarcoma. A variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol. 1995;19(9):979–93.

    Article  CAS  PubMed  Google Scholar 

  143. Antonescu CR, Rosenblum MK, Pereira P, Nascimento AG, Woodruff JM. Sclerosing epithelioid fibrosarcoma: a study of 16 cases and confirmation of a clinicopathologically distinct tumor. Am J Surg Pathol. 2001;25(6):699–709.

    Article  CAS  PubMed  Google Scholar 

  144. Wang WL, Evans H, Meis JM, Liegl-Atzwanger B, Bovee JV, Goldblum JR, et al. FUS rearrangements are rare in ‘pure’ sclerosing epithelioid fibrosarcoma. Mod Pathol. 2012;25(6):846–53.

    Article  PubMed  Google Scholar 

  145. Doyle LA, Wang WL, Dal Cin P, Lopez-Terrada D, Mertens F, Lazar AJ, et al. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol. 2012;36(10):1444–51.

    Article  PubMed  Google Scholar 

  146. Italiano A, Penel N, Robin YM, Bui B, Le Cesne A, Piperno-Neumann S, et al. Neo/adjuvant chemotherapy does not improve outcome in resected primary synovial sarcoma: a study of the French Sarcoma Group. Ann Oncol. 2009;20(3):425–30.

    Article  CAS  PubMed  Google Scholar 

  147. Alaggio R, Coffin CM, Vargas SO. Soft tissue tumors of uncertain origin. Pediatr Dev Pathol. 2012;15(1 Suppl):267–305.

    Article  PubMed  Google Scholar 

  148. Soria-Cespedes D, Galván-Linares AI, Oros-Ovalle C, Gaitan-Gaona F, Ortiz-Hidalgo C. Primary monophasic synovial sarcoma of the tonsil: immunohistochemical and molecular study of a case and review of the literature. Head Neck Pathol. 2013;7(4):400–3.

    Article  PubMed  PubMed Central  Google Scholar 

  149. Boudin L, Fakhry N, Chetaille B, Perrot D, Nguyen AT, Daidj N, et al. Primary synovial sarcoma of the thyroid gland: case report and review of the literature. Case Rep Oncol. 2014;7(1):6–13.

    Article  PubMed  PubMed Central  Google Scholar 

  150. Rigante M, Visocchi M, Petrone G, Mulè A, Bussu F. Synovial sarcoma of the parotid gland: a case report and review of the literature. Acta Otorhinolaryngol Ital. 2011;31(1):43–6.

    CAS  PubMed  Google Scholar 

  151. Kerouanton A, Jimenez I, Cellier C, Laurence V, Helfre S, Pannier S, et al. Synovial sarcoma in children and adolescents. J Pediatr Hematol Oncol. 2014;36(4):257–62.

    Article  CAS  PubMed  Google Scholar 

  152. Guillou L, Benhattar J, Bonichon F, Gallagher G, Terrier P, Stauffer E, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004;22(20):4040–50.

    Article  PubMed  Google Scholar 

  153. Gebhard S, Coindre JM, Michels JJ, Terrier P, Bertrand G, Trassard M, et al. Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases. Am J Surg Pathol. 2002;26(5):601–16.

    Article  PubMed  Google Scholar 

  154. Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, et al. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age. Am J Surg Pathol. 2009;33(5):645–58.

    Article  PubMed  Google Scholar 

  155. Mariño-Enríquez A, Fletcher CD, Dal Cin P, Hornick JL. Dedifferentiated liposarcoma with “homologous” lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Am J Surg Pathol. 2010;34(8):1122–31.

    Article  PubMed  Google Scholar 

  156. Hornick JL, Bosenberg MW, Mentzel T, McMenamin ME, Oliveira AM, Fletcher CD. Pleomorphic liposarcoma: clinicopathologic analysis of 57 cases. Am J Surg Pathol. 2004;28:1257–67.

    Article  PubMed  Google Scholar 

  157. Gerry D, Fox NF, Spruill LS, Lentsch EJ. Liposarcoma of the head and neck: analysis of 318 cases with comparison to non-head and neck sites. Head Neck. 2014;36(3):393–400.

    Article  PubMed  Google Scholar 

  158. Nascimento AF, McMenamin ME, Fletcher CD. Liposarcomas/atypical lipomatous tumors of the oral cavity: a clinicopathologic study of 23 cases. Ann Diagn Pathol. 2002;6(2):83–93.

    Article  PubMed  Google Scholar 

  159. Nilbert M, Rydholm A, Mitelman F, Meltzer PS, Mandahl N. Characterization of the 12q13-15 amplicon in soft tissue tumors. Cancer Genet Cytogenet. 1995;83(1):32–6.

    Article  CAS  PubMed  Google Scholar 

  160. Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagacé R, et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol. 2005;29(10):1340–7.

    Article  PubMed  Google Scholar 

  161. Antonescu CR, Ladanyi M. Myxoid liposarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 39–41.

    Google Scholar 

  162. Antonescu CR, Elahi A, Humphrey M, Lui MY, Healey JH, Brennan MF, et al. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. J Mol Diag. 2000;2(3):132–8.

    Article  CAS  Google Scholar 

  163. Pitson G, Robinson P, Wilke D, Kandel RA, White L, Griffin AM, et al. Radiation response: an additional unique signature of myxoid liposarcoma. Int J Rad Oncol Biol Phys. 2004;60(2):522–6.

    Article  Google Scholar 

  164. Miettinen M, Enzinger FM. Epithelioid variant of pleomorphic liposarcoma: a study of 12 cases of a distinctive variant of high-grade liposarcoma. Mod Pathol. 1999;12(7):722–8.

    CAS  PubMed  Google Scholar 

  165. Folpe AL, Deyrup AT. Alveolar soft-part sarcoma: a review and update. J Clin Pathol. 2006;59(11):1127–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  166. Font RL, Jurco S, Zimmerman LE. Alveolar soft-part sarcoma of the orbit: a clinicopathologic analysis of seventeen cases and a review of the literature. Hum Pathol. 1982;13(6):569–79.

    Article  CAS  PubMed  Google Scholar 

  167. Fanburg-Smith JC, Miettinen M, Folpe AL, Weiss SW, Childers EL. Lingual alveolar soft part sarcoma; 14 cases: novel clinical and morphological observations. Histopathology. 2004;45(5):526–37.

    Article  CAS  PubMed  Google Scholar 

  168. Pennacchioli E, Fiore M, Collini P, Radelli S, Dileo P, Stacchiotti S, et al. Alveolar soft part sarcoma: clinical presentation, treatment, and outcome in a series of 33 patients at a single institution. Ann Surg Oncol. 2010;17(12):3229–33.

    Article  PubMed  Google Scholar 

  169. Kayton ML, Meyers P, Wexler LH, Gerald WL, LaQuaglia MP. Clinical presentation, treatment, and outcome of alveolar soft part sarcoma in children, adolescents, and young adults. J Pediatr Surg. 2006;41(1):187–93.

    Article  PubMed  Google Scholar 

  170. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27(6):750–61.

    Article  PubMed  Google Scholar 

  171. Ordóñez NG, Ladanyi M. Alveolar soft part sarcoma. In: Fletcher CDM, Bridge JA, Hogendoorn PC, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013. p. 218–20.

    Google Scholar 

  172. Stacchiotti S, Tamborini E, Marrari A, Brich S, Rota SA, Orsenigo M, et al. Response to sunitinib malate in advanced alveolar soft part sarcoma. Clin Cancer Res. 2009;15(3):1096–104.

    Article  CAS  PubMed  Google Scholar 

  173. Dei Tos AP, Wadden C, Fletcher CD. Extraskeletal myxoid chondrosarcoma: an immunohistochemical reappraisal of 39 cases. Appl Immunohistochem. 1997;5(2):73–7.

    Article  Google Scholar 

  174. Antonescu CR, Argani P, Erlandson RA, Healey JH, Ladanyi M, Huvos AG. Skeletal and extraskeletal myxoid chondrosarcoma: a comparative clinicopathologic, ultrastructural, and molecular study. Cancer. 1998;83(8):1504–21.

    Article  CAS  PubMed  Google Scholar 

  175. Oshiro Y, Shiratsuchi H, Tamiya S, Oda Y, Toyoshima S, Tsuneyoshi M. Extraskeletal myxoid chondrosarcoma with rhabdoid features, with special reference to its aggressive behavior. Int J Surg Pathol. 2000;8(2):145–52.

    Article  PubMed  Google Scholar 

  176. Hisaoka M, Hashimoto H. Extraskeletal myxoid chondrosarcoma: updated clinicopathological and molecular genetic characteristics. Pathol Int. 2005;55(8):453–63.

    Article  PubMed  Google Scholar 

  177. Flucke U, Tops BB, Verdijk MA, van Cleef PJ, van Zwam PH, Slootweg PJ, et al. NR4A3 rearrangement reliably distinguishes between de clinicopathologically overlapping entities myoepithelial carcinoma of soft tissue and cellular extraskeletal myxoid chondrosarcoma. Virchows Arch. 2012;460(6):621–8.

    Article  PubMed  PubMed Central  Google Scholar 

  178. Drilon AD, Popat S, Bhuchar G, D’Adamo DR, Keohan ML, Fisher C, et al. Extraskeletal myxoid chondrosarcoma: a retrospective review from 2 referral centers emphasizing long-term outcomes with surgery and chemotherapy. Cancer. 2008;113(12):3364–71.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uta Flucke MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Flucke, U., Slootweg, P.J. (2016). Soft Tissue Lesions. In: Cardesa, A., Slootweg, P., Gale, N., Franchi, A. (eds) Pathology of the Head and Neck. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-49672-5_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-49672-5_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-49670-1

  • Online ISBN: 978-3-662-49672-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics